US › Healthcare

908 Devices Inc (MASS)

US · Healthcare · Medical Devices

$8.45+0.36%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$13.4M
Revenue YoY
+13.6%
Net profit
$-12.0M
Profit YoY
-127.4%
EPS
$-0.07
EPS estimate
$-0.14
Net margin
-89.3%

EPS came in at -0.07 against a street estimate of -0.14 — a beat of 50.0%.

Key statistics

Market cap
$328.6M
Forward P/E
0.0
P/B
2.45
Book value
$3.59
EPS (TTM)
$-0.97
52-week high
$9.34
52-week low
$5.03
50-day MA
$8.10
200-day MA
$6.99
Beta
0.63

Analyst view

Analysts rate 908 Devices Inc a strong buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $11.00.

Shareholding

Insiders
8.21%
Institutions
82.85%

Largest institutional holders

FundStake
First Light Asset Management, LLC14.80%
Awm Investment Company Inc12.67%
ARK Investment Management LLC4.74%
BlackRock Inc4.31%
Needham Investment Management, LLC3.02%
Vanguard Capital Management, LLC2.73%
Arnhold & S. Bleichroeder Advisers, LLC1.96%
Geode Capital Management, LLC1.70%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for 908 Devices Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.